US Broker Ratings

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth

Phreesia, Inc. (PHR), a prominent player in the healthcare sector, specializes in providing an integrated SaaS-based software and payment platform designed to streamline operations for healthcare organizations across the United..

Opko Health, Inc. (OPK): Investor Outlook Reveals Massive 233.97% Upside Potential

As the healthcare sector continues to draw significant investor interest, Opko Health, Inc. (NASDAQ: OPK) stands out with its remarkable potential upside of 233.97%. Headquartered in Miami, Florida, Opko Health..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a Promising 41.84% Upside Potential

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the healthcare sector under the medical devices industry, has caught the attention of investors with its innovative solutions for diabetes..

Organon & Co. (OGN) Stock Analysis: Valuation Insights and Investor Outlook Amidst Market Challenges

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, specializes in developing women’s health solutions, biosimilars, and a diverse range of therapeutic products. With its headquarters in..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating Growth in the Diagnostics Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the healthcare sector with its innovative approach to diagnostics and research. As a commercial-stage company, Adaptive Biotechnologies focuses on developing an..

Novavax, Inc. (NVAX) Stock Analysis: Is a 90% Upside Potential Worth the Risk?

Navigating the biotechnology landscape often involves a high-stakes balance of risk and reward. Novavax, Inc. (NASDAQ: NVAX) is currently at the center of this dynamic, offering investors both a substantial..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing a 53.66% Potential Upside in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is making waves in the biotechnology sector with its strategic focus on developing therapeutics for eye care. Headquartered in Irvine, California, the company is positioning..

PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a Potential 54.81% Upside Amidst Urological Innovation

Investors looking to tap into the burgeoning field of surgical robotics may find PROCEPT BioRobotics Corporation (NASDAQ: PRCT) an intriguing prospect. Specializing in medical devices within the healthcare sector, PROCEPT..

Twist Bioscience Corporation (TWST) Stock Analysis: A Biotech Innovator with Mixed Signals for Investors

Twist Bioscience Corporation (NASDAQ: TWST), a leading player in the synthetic biology sector, has been capturing investor attention with its cutting-edge offerings in synthetic DNA-based products. With a current stock..

BGM Group Ltd. (BGM) Stock Analysis: Navigating the Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector focusing on drug manufacturing, is currently navigating a complex financial landscape. Based in Chengdu, China, BGM has a market capitalization..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Navigating High Expectations with Cutting-Edge Medical Innovations

Pulse Biosciences, Inc. (NASDAQ: PLSE), a promising player in the healthcare sector, is making waves with its pioneering bioelectric medicine technologies. Despite its relatively young establishment in 2014, the company..

Certara, Inc. (CERT) Stock Analysis: Navigating the Healthcare Sector with Technology-Driven Solutions

Investors eyeing opportunities in the healthcare sector might find Certara, Inc. (NASDAQ: CERT) a company worth examining. As a provider of innovative technology-driven services and software products, Certara caters to..

CG Oncology, Inc. (CGON) Stock Analysis: Potential 31.15% Upside in Biotech Sector

Investors eyeing the biotechnology sector should pay close attention to CG Oncology, Inc. (NASDAQ: CGON), a prominent player in the healthcare industry. With a market capitalization of $6.1 billion, CG..

Belite Bio, Inc (BLTE) Investor Outlook: Unveiling a 35.99% Potential Upside in Biotech Innovation

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, has captured investor attention with its cutting-edge research and development focus. With a robust market capitalization of $6.2 billion,..

Innoviva, Inc. (INVA) Stock Analysis: Biotech Powerhouse with 70% Upside Potential

Innoviva, Inc. (NASDAQ: INVA), a biopharmaceutical company based in Burlingame, California, is making waves in the biotechnology sector with its promising portfolio and strategic collaborations. With a current market cap..

LivaNova PLC (LIVN) Stock Analysis: Navigating Growth in Healthcare with a 14.3% Revenue Surge

LivaNova PLC (NASDAQ: LIVN) stands at the forefront of medical innovation, showcasing a promising trajectory within the healthcare sector. With its roots in the United Kingdom, LivaNova operates across two..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Analyst Consensus Points to 36% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a key player in the healthcare sector specializing in drug manufacturing for opioid dependence treatment, has garnered significant investor interest. Headquartered in North Chesterfield, Virginia,..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Beckons for Investors

AdaptHealth Corp. (NASDAQ: AHCO) is capturing the attention of investors with a compelling potential upside of over 30%, according to analyst price targets. Specializing in the distribution of home medical..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Potential 69% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $3.02 billion, this United States-based company is..

Omnicell, Inc. (OMCL)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds